Insider Selling: Doximity, Inc. (NASDAQ:DOCS) Insider Sells 1,500 Shares of Stock

Doximity, Inc. (NASDAQ:DOCS - Get Free Report) insider Craig Overpeck sold 1,500 shares of the business's stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $23.85, for a total transaction of $35,775.00. Following the sale, the insider now directly owns 108,609 shares in the company, valued at $2,590,324.65. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.

Doximity Trading Up 18.1 %

Shares of Doximity stock traded up $4.29 during trading hours on Friday, reaching $28.03. The stock had a trading volume of 9,867,164 shares, compared to its average volume of 1,799,228. The stock's 50 day moving average is $25.65 and its 200 day moving average is $26.38. The firm has a market capitalization of $5.23 billion, a PE ratio of 41.82, a PEG ratio of 3.00 and a beta of 1.18. Doximity, Inc. has a twelve month low of $19.71 and a twelve month high of $36.29.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the stock. Creative Financial Designs Inc. ADV raised its position in shares of Doximity by 16.7% during the 4th quarter. Creative Financial Designs Inc. ADV now owns 3,301 shares of the company's stock worth $93,000 after purchasing an additional 473 shares during the last quarter. Treasurer of the State of North Carolina grew its stake in Doximity by 1.0% during the 4th quarter. Treasurer of the State of North Carolina now owns 53,128 shares of the company's stock valued at $1,490,000 after acquiring an additional 520 shares in the last quarter. First Horizon Advisors Inc. grew its stake in Doximity by 111.3% during the 4th quarter. First Horizon Advisors Inc. now owns 995 shares of the company's stock valued at $28,000 after acquiring an additional 524 shares in the last quarter. Ieq Capital LLC grew its stake in Doximity by 0.6% during the 3rd quarter. Ieq Capital LLC now owns 99,539 shares of the company's stock valued at $2,112,000 after acquiring an additional 573 shares in the last quarter. Finally, Perigon Wealth Management LLC grew its stake in Doximity by 4.5% during the 1st quarter. Perigon Wealth Management LLC now owns 15,598 shares of the company's stock valued at $420,000 after acquiring an additional 676 shares in the last quarter. Institutional investors and hedge funds own 87.19% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on DOCS shares. Leerink Partnrs reissued a "market perform" rating on shares of Doximity in a report on Monday, February 26th. JPMorgan Chase & Co. raised shares of Doximity from an "underweight" rating to a "neutral" rating and set a $25.00 price objective on the stock in a report on Thursday, April 25th. Evercore ISI boosted their price objective on shares of Doximity from $28.00 to $29.00 and gave the company an "in-line" rating in a report on Friday. Bank of America boosted their price objective on shares of Doximity from $29.00 to $32.00 and gave the company a "neutral" rating in a report on Tuesday, January 23rd. Finally, SVB Leerink assumed coverage on shares of Doximity in a research report on Monday, February 26th. They set a "market perform" rating and a $32.00 target price for the company. One research analyst has rated the stock with a sell rating, eleven have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $28.73.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.